Correspondence 0000950170-23-022706 from iTeos Therapeutics, Inc. (ITOS) (CIK 0001808865)
iTeos Therapeutics, Inc. (ITOS) (CIK 0001808865)
Date: May 17, 2023 · CIK: 0001808865 · Accession: 0000950170-23-022706
AI Filing Summary & Sentiment
File numbers found in text: 333-271793
Letter
United States Belgium
321 Arsenal Street Rue des Freres Wright
Bldg 312, Suite 301 6041 Gosselies, Belgium
Watertown, MA 02472-5710
May 17, 2023
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Re:
iTeos Therapeutics, Inc.
Registration Statement on Form S-3 (File No. 333-271793)
Request for Acceleration
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, iTeos Therapeutics, Inc., a Delaware corporation (the “Company”), hereby requests that the effective date for the registration statement referred to above be accelerated so that it will be declared effective at 4:00 p.m. Eastern Time on May 19, 2023, or as soon as possible thereafter. The Company hereby authorizes Paul Kinsella or William Michener of Ropes & Gray LLP, counsel to the Company, to orally modify or withdraw this request for acceleration. Please notify William Michener of Ropes & Gray LLP, counsel to the Company, at (617) 951-7247 as soon as the registration statement has been declared effective.
Very truly yours,
ITEOS THERAPEUTICS, INC.
Show Raw Text
CORRESP
1
filename1.htm
CORRESP
United States Belgium
321 Arsenal Street Rue des Freres Wright
Bldg 312, Suite 301 6041 Gosselies, Belgium
Watertown, MA 02472-5710
May 17, 2023
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Re:
iTeos Therapeutics, Inc.
Registration Statement on Form S-3 (File No. 333-271793)
Request for Acceleration
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, iTeos Therapeutics, Inc., a Delaware corporation (the “Company”), hereby requests that the effective date for the registration statement referred to above be accelerated so that it will be declared effective at 4:00 p.m. Eastern Time on May 19, 2023, or as soon as possible thereafter. The Company hereby authorizes Paul Kinsella or William Michener of Ropes & Gray LLP, counsel to the Company, to orally modify or withdraw this request for acceleration. Please notify William Michener of Ropes & Gray LLP, counsel to the Company, at (617) 951-7247 as soon as the registration statement has been declared effective.
Very truly yours,
ITEOS THERAPEUTICS, INC.
By: /s/ Matthew Gall
Matthew Gall
Chief Financial Officer
iteostherapeutics.com